Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Fedricker Diane Barber"'
Autor:
Fedricker Diane Barber
Publikováno v:
Asia-Pacific Journal of Oncology Nursing, Vol 6, Iss 3, Pp 212-226 (2019)
Over the past two decades, immunotherapy has emerged as a promising treatment option for patients with cancer. However, newer versions of immunotherapy, such as checkpoint inhibitors, may be associated with unusual adverse effects (AEs) that can rang
Externí odkaz:
https://doaj.org/article/95e6aaf4d98841fb9a81a0638597c92e
Autor:
Fedricker Diane Barber
Publikováno v:
Asia-Pacific Journal of Oncology Nursing, Vol 8, Iss 1, Pp 103-105 (2021)
Asia-Pacific Journal of Oncology Nursing
Asia-Pacific Journal of Oncology Nursing
Posterior reversible encephalopathy syndrome (PRES) is a rare potential immune-related adverse event (irAE) of checkpoint inhibitors. PRES is a disorder that has a variety of clinical and radiological features, which makes it a challenge for advanced
Publikováno v:
Clinical journal of oncology nursing. 24(5)
Phase 1 clinical trials are essential to improving outcomes in cancer care. The investigational agents in these trials may be associated with adverse events that can contribute to symptom burden and declining performance status for trial participants
Autor:
Kristine B. LeFebvre, Lorinda A. Coombs, Heather Mackey, Tamika Turner, Kimberly Noonan, Fedricker Diane Barber, Mary Peterson
Publikováno v:
Clin J Oncol Nurs
Background The oncology nurse practitioner (ONP) role has evolved since the first ONP competencies were published by the Oncology Nursing Society in 2007. An update was completed in 2019 to reflect the rapidly expanding role. Objectives The purpose o
Publikováno v:
Clinical journal of oncology nursing. 24(1)
Background Advance care planning (ACP) is an ongoing process of communication involving patients, family members, and caregivers on one side and healthcare providers on the other to establish values, goals, and preferences for future care, along with
Autor:
Fedricker Diane Barber
Publikováno v:
The Journal for Nurse Practitioners. 14:259-266
Immunotherapy has emerged as a promising treatment for cancer survivors in the past few years. This new treatment is associated with unique immune-related toxicities that can range from mild to life-threatening. Early recognition, referral, and monit
Autor:
Fedricker Diane Barber, Ellen Mullen
Publikováno v:
The Journal for Nurse Practitioners. 13:328-335
Multiple myeloma is a hematologic disease characterized by an excessive number of abnormal plasma cells that infiltrate the bone marrow and overproduction of monoclonal immunoglobulins. It is the third most prevalent hematologic disease and makes up
Publikováno v:
Clinical journal of oncology nursing. 20(3)
The United States has a well-documented shortage of primary care providers (PCPs) and oncologists. Cancer survivors are living longer because of advances in treatment, and, consequently, more are seeking survivorship care from PCPs; this trend is pre
Autor:
Fedricker Diane Barber
Publikováno v:
Clinical Journal of Oncology Nursing. 16:E84-E98
Less than 20% of adult cancer survivors participate in physical activity and, as a result of such inactivity, cancer survivors are at increased risk for developing chronic diseases. Studies have linked social support as a predictor of physical activi
Autor:
Fedricker Diane Barber
Publikováno v:
The Journal for Nurse Practitioners. 2:665-672
Multiple myeloma is a progressive hematologic disease characterized by an excessive number of abnormal plasma cells that infiltrate the bone marrow by the overproduction of monoclonal immunoglobulin (IgG, IgA, IgD, or IgE) or Bence-Jones protein that